/Lists

Biotech Series B Investors & VC Firms

724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.

Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
15 people
INCE Capital
ShanghaiSeed–Growth
12 people
JK&B Capital
ChicagoSeed–Late Stage
9 people
BrightEdge
AtlantaPre-Seed–Late Stage
15 people
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Growth$16.2M
16 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
EFung Capital
ShenzhenSeries A–Growth
Grazia Equity GmbH
StuttgartSeed–Growth$540K – $2.7M
9 people
Life Sciences Greenhouse Investments
HarrisburgPre-Seed–Series B$250K – $500K
12 people
NovaCapital
Seed–Late Stage
9 people
Gilead Sciences
Foster CitySeries B–Late Stage
19 people
Seroba Life Sciences
DublinSeed–Growth$540K – $7.6M
13 people
Bios Partners
Fort WorthSeed–Growth
17 people
Quadrille Capital
ParisSeed–Late Stage
15 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
19 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
17 people
Synthesis Capital
LondonSeries A–Series C
17 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
GSR United Capital
BeijingSeed–Growth
Smilegate Investment
SeoulSeed–Series B$500K
15 people
LifeSci Venture Partners
New YorkSeries A–Series C
6 people
Mérieux Equity Partners
ParisSeed–Growth$3.2M – $86M
14 people
Tenmile
Seed–Series B
11 people
America's Frontier Fund
ArlingtonSeed–Growth$500K – $10M
13 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.